Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

ADHD Market Hurt By Safety Concerns, Lilly Says

Mar 29 2005

• By Nielsen Hobbs

Related Content

Lilly Tells Physicians To Have Patience With Strattera

Jan 13 2005

Strattera Labeling Adds Bolded Warning For Severe Liver Injury

Dec 17 2004

Shire Adderall XR Sales Suspended In Canada; FDA Stands By "Black Box"

Feb 10 2005

Shire To Begin Promoting Adderall XR Adult Indication

Aug 12 2004

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window